Autonomic Testing for Syncope and Fall Evaluation in Neurology

Clinical Challenges in Syncope and Fall Evaluation In clinical neurology, managing patients with unexplained syncope or frequent falls represents a significant diagnostic hurdle. Often, these events are manifestations of underlying autonomic dysfunction falls that standard neurological exams may overlook. When a patient presents with recurrent loss of consciousness or instability, differentiating between cardiac, neurological, and dysautonomic etiologies is critical. The traditional approach often leads to expensive and time-consuming diagnostic odysseys. However, integrating objective autonomic testing syncope protocols into a neurological practice can rapidly identify patterns of orthostatic intolerance and vasomotor instability that drive these clinical events. ## The Role of Autonomic Dysfunction in Falls and Syncope Patients with autonomic failure or neuropathy often demonstrate poor compensatory responses to positional changes. Vasovagal syncope remains a common diagnosis, but identifying the specific autonomic deficit—be it sympathetic failure or impaired baroreceptor sensitivity—is essential for targeted management. By utilizing the VitalScan ANS+ system, clinicians can assess cardiovascular and vascular integrity in a standardized, non-invasive manner. This objective data is invaluable for clinicians attempting to determine if a patient's falls are primarily neurologic, vestibulopathic, or cardiovascular in origin. ## Clinical Implementation of the VitalScan ANS+ System The VitalScan ANS+ system, manufactured by US MedResources, offers a streamlined approach to evaluating complex patients within a 15-minute window. Because the test can be administered by existing clinical staff, it integrates seamlessly into high-volume neurology clinics without requiring a specialized technician. The system provides a comprehensive assessment, including Heart Rate Variability (HRV), Valsalva ratio, orthostatic blood pressure response, sudomotor function (SudoCheck), and vascular markers such as Pulse Wave Velocity (PWV) and Ankle-Brachial Index (ABI). ### Diagnostic Accuracy and Interpretive Reporting A significant advantage of the VitalScan ANS+ is the availability of an automated interpretive report immediately following the testing session. This allows the neurologist to review the findings and initiate a treatment plan before the patient leaves the office. By capturing real-time hemodynamic responses to postural transitions, the system provides clear evidence of orthostatic intolerance that might be missed during a standard physical exam. These diagnostics align with evidence-based criteria supported by the American Heart Association (AHA) and American College of Cardiology (ACC) regarding the management of syncope and cardiovascular risk. ## Billing and Practice Integration For practice managers, the clinical value of the VitalScan ANS+ is complemented by its billing viability. The diagnostic procedures conducted by the device are supported by established CPT codes, specifically 95921-95924 for autonomic nervous system testing and 93922-93971 for vascular studies. Given the 30-year track record of the technology, US MedResources has ensured that the platform meets the rigorous demands of modern medical practices seeking to provide efficient, high-quality care. By addressing unexplained syncope and falls through objective autonomic testing, practices can improve patient safety, reduce hospital readmissions, and optimize patient outcomes. ### Key Takeaway Incorporating the VitalScan ANS+ system into your neurology practice allows for the rapid identification of autonomic dysfunction in patients with syncope and falls. By utilizing CPT codes 95921-95924 and 93922-93971, you can achieve a sustainable, evidence-based diagnostic workflow that objectively measures orthostatic intolerance and vasomotor function, leading to improved management of complex neurological patients.